426833-07-0

Basic information

• Product Name: (-)-(2R,3R)-4-benzyloxy-3-hydroxy-2-methyl-1-phenyl-butan-1-one
• Synonyms: (-)-(2R,3R)-4-benzyloxy-3-hydroxy-2-methyl-1-phenyl-butan-1-one
• CAS NO: 426833-07-0
• Molecular Weight: 284.355
• Mol File: 426833-07-0.mol

Chemical Properties

• CAS DataBase Reference: (-)-(2R,3R)-4-benzyloxy-3-hydroxy-2-methyl-1-phenyl-butan-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: (-)-(2R,3R)-4-benzyloxy-3-hydroxy-2-methyl-1-phenyl-butan-1-one(426833-07-0)
• EPA Substance Registry System: (-)-(2R,3R)-4-benzyloxy-3-hydroxy-2-methyl-1-phenyl-butan-1-one(426833-07-0)

Safety Data

• Hazardous Substances Data: 426833-07-0(Hazardous Substances Data)

Upstream product

• 642993-51-9 1-(1H-benzotriazol-1-yl)-2-benzyloxyethan-1-one 
• 93-55-0 1-phenyl-propan-1-one 
• 30379-55-6 benzyloxyacetic acid 
• 426833-01-4 4-benzyloxy-2-methyl-1-phenylbutane-1,3-dione 

Downstream Products

• 642993-70-2 (S)-4-Benzyl-3-[(2S,3R,4S,5R)-6-benzyloxy-5-(tert-butyl-dimethyl-silanyloxy)-3-hydroxy-2,4-dimethyl-hexanoyl]-oxazolidin-2-one 
• 642993-74-6 2-[(1S,2R,3S,4R)-5-Benzyloxy-2,4-bis-(tert-butyl-dimethyl-silanyloxy)-1,3-dimethyl-pentyl]-[1,3]dithiane 
• 643727-58-6 (+)-(2S,3R,4S,5R)-6-benzyloxy-3,5-bis(tert-butyldimethylsiloxy)-2,4-dimethyl-N-methoxy-N-methylhexanamide 
• 643727-59-7 (+)-(2S,3R,4S,5R)-6-benzyloxy-3,5-bis(tert-butyldimethylsiloxy)-2,4-dimethylhexanal 
• 642993-72-4 (+)-(2S,3R,4S,5R)-6-benzyloxy-5-(tert-butyldimethylsiloxy)-3-hydroxy-2,4-dimethyl-N-methoxy-N-methylhexanamide 
• 643727-57-5 (-)-phenyl (2R,3R)-4-benzyloxy-3-(tert-butyldimethylsiloxy)-2-methylbutyrate 
• 642993-67-7 (2R,3R)-4-(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-2-methylbutanal 
• 501419-25-6 (+)-(2S,3R)-4-benzyloxy-3-(tert-butyldimethylsiloxy)-2-methylbutan-1-ol 
• 642993-64-4 (-)-phenyl (2R,3R)-4-benzyloxy-3-hydroxy-2-methylbutanoate 

Relevant articles and documents

Synthesis of the C14-C25 Subunit of Bafilomycin A1

The enantioselective synthesis of the C14-C25 subunit of bafilomycin A 1, was realized in a convergent route. The sequence involves two dynamic kinetic resolution steps of 2-alkyl 1,3-diketones that use optically active ruthenium complexes, an

Enantioselective monoreduction of 2-alkyl 1,3-diketones using chiral ruthenium catalysts. Synthesis of the C14-C25 fragment of bafilomycin A 1

The enantioselective monoreduction of 2-alkyl 1,3-diketones by dynamic kinetic resolution using optically active ruthenium catalysts allowed the preparation of the C14-C25 fragment of bafilomycin A1.

Enantioselective Monoreduction of 2-Alkyl-1,3-diketones Mediated by Chiral Ruthenium Catalysts. Dynamic Kinetic Resolution

(Matrix Presented) The reduction of 2-alkyl-1,3-diketones using (R,R)- or (S,S)-RuCl[N-(tosyl)-1,2-diphenylethylenediamine](p-cymene) in the presence of formic acid and triethylamine affords syn-2-alkyl-3-hydroxy ketones as the major products with high en